Please use this identifier to cite or link to this item: http://hdl.handle.net/1942/49801
Full metadata record
DC FieldValueLanguage
dc.contributor.authorDe Weerdt, Louise-
dc.contributor.authorThiriard, Anais-
dc.contributor.authorDuc, Ines Vu-
dc.contributor.authorReviya, Nina-
dc.contributor.authorVan Damme, Pierre-
dc.contributor.authorHENS, Niel-
dc.contributor.authorMarchant, Arnaud-
dc.contributor.authorMaertens, Kirsten-
dc.date.accessioned2026-08-17T06:31:05Z-
dc.date.available2026-08-17T06:31:05Z-
dc.date.issued2026-
dc.date.submitted2026-08-17T06:23:59Z-
dc.identifier.citationVaccine, 88 (Art N° 128953)-
dc.identifier.urihttp://hdl.handle.net/1942/49801-
dc.description.abstractBackground: Tetanus, diphtheria, acellular pertussis (Tdap) vaccination in pregnancy protects newborns against pertussis, but the influence of gestational age (GA) at vaccination on maternal and neonatal immune profiles remains incompletely understood. This study aimed to characterize the effect of GA at Tdap vaccination on several antibody features during pregnancy and at birth, and to assess transplacental antibody transfer. Methods: 96 pregnant women received Tdap at different GAs between week 16 and 32 within a Belgian, prospective non-randomized controlled trial. Maternal blood was collected pre-vaccination, at multiple timepoints post-vaccination, and at delivery, alongside cord blood at birth. Tdap-specific total IgG and IgG subclasses were evaluated alongside Fc-mediated effector functions. Multivariate analyses were applied to define composite immune patterns. Results: Post-vaccination, robust immune responses were observed across cohorts. At delivery, maternal total IgG and IgG1 against PRN, DT, and TT were higher with later vaccination, whereas other subclasses and functional responses were largely comparable. Cord blood profiles partially paralleled maternal patterns without reaching significance, and no significant effect of vaccination-to-delivery interval was detected. IgG transfer ratios generally declined with advancing GA; functional antibody transfer was largely unaffected. Multivariate analyses highlighted higher maternal antibody response profiles at delivery with later vaccination, while cord blood profiles were generally unaffected. Conclusion: Maternal Tdap antibody response profiles at delivery are influenced by vaccination timing, while neonatal antibody profiles at birth appear largely comparable within the limits of the study. These findings support current recommendations for Tdap administration between 16 and 32 weeks of gestation and underscore the flexibility of this window for routine antenatal care.-
dc.description.sponsorshipFinancial support The authors declare financial support was received for the research, authorship, and/or publication of this article. This project was funded by the Research Foundation – Flanders (FWO, G039721N and G004723N). Acknowledgments The authors thank all participating women. The authors also thank the study nurse Annemie Bruynseels who performed repeated home visits and blood sampling.-
dc.language.isoen-
dc.publisherELSEVIER SCI LTD-
dc.rights2026 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/)-
dc.subject.otherPertussisTdap-
dc.subject.otherGestational age-
dc.subject.otherTiming-
dc.subject.otherAntibody profile-
dc.subject.otherSystems serology-
dc.titleTiming of maternal Tdap vaccination: A dynamic balance between antibody induction and placental transfer efficiency-
dc.typeJournal Contribution-
dc.identifier.volume88-
local.format.pages11-
local.bibliographicCitation.jcatA1-
dc.description.notesDe Weerdt, L; Maertens, K (corresponding author), Univ Antwerp, Vaccine & Infect Dis Inst, Ctr Evaluat Vaccinat, Antwerp, Belgium.-
dc.description.noteskirsten.maertens@uantwerpen.be; louise.deweerdt@uantwerpen.be-
local.publisher.place125 London Wall, London, ENGLAND-
local.type.refereedRefereed-
local.type.specifiedArticle-
local.bibliographicCitation.artnr128953-
dc.identifier.doi10.1016/j.vaccine.2026.128953-
dc.identifier.pmid42472495-
dc.identifier.isi001828094400001-
local.provider.typewosris-
local.description.affiliation[De Weerdt, Louise; Reviya, Nina; Van Damme, Pierre; Maertens, Kirsten] Univ Antwerp, Vaccine & Infect Dis Inst, Ctr Evaluat Vaccinat, Antwerp, Belgium; [Thiriard, Anais; Duc, Ines Vu; Marchant, Arnaud] Univ Libre Bruxelles, European Plotkin Inst Vaccinol, Brussels, Belgium; [Hens, Niel] Univ Antwerp, Vaccine & Infect Dis Inst, Ctr Hlth Econ Res & Modelling Infect Dis, Antwerp, Belgium; [Hens, Niel] Hasselt Univ, Interuniv Inst Biostat & Stat Bioinformat, Data Sci Inst, Hasselt, Belgium-
local.uhasselt.internationalno-
item.fulltextWith Fulltext-
item.fullcitationDe Weerdt, Louise; Thiriard, Anais; Duc, Ines Vu; Reviya, Nina; Van Damme, Pierre; HENS, Niel; Marchant, Arnaud & Maertens, Kirsten (2026) Timing of maternal Tdap vaccination: A dynamic balance between antibody induction and placental transfer efficiency. In: Vaccine, 88 (Art N° 128953).-
item.contributorDe Weerdt, Louise-
item.contributorThiriard, Anais-
item.contributorDuc, Ines Vu-
item.contributorReviya, Nina-
item.contributorVan Damme, Pierre-
item.contributorHENS, Niel-
item.contributorMarchant, Arnaud-
item.contributorMaertens, Kirsten-
item.accessRightsOpen Access-
crisitem.journal.issn0264-410X-
crisitem.journal.eissn1873-2518-
Appears in Collections:Research publications
Files in This Item:
File Description SizeFormat 
main.pdfPublished version8.19 MBAdobe PDFView/Open
Show simple item record

Google ScholarTM

Check

Altmetric


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.